"Biotage shall provide customers with efficient, sustainable separation science and chemical synthesis solutions through innovation, expertise and a dedication to solve customer needs."
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, China, Korea and Japan. Biotage has approximately 330 employees and had sales of 667 MSEK in 2016. Biotage is listed on the NASDAQ OMX Nordic.
The group aims to accelerate the drug discovery and development process, and to increase knowledge by providing complete solutions for Medicinal and Analytical Chemistry and Process Development. The company aims to be market leading in each of its niche areas.
The company has a strong customer base of industry and academic partners, which include the world’s top 20 pharmaceutical companies and prestigious academic institutes such as the US National Institutes of Health, the US Centers for Disease Control and Prevention and the Karolinska Institute in Sweden.
Headquartered in Uppsala, Sweden, Biotage AB also has facilities in Lund, Sweden; Charlotte, NC, USA; Cardiff, UK; Bundang, Korea; Tokyo and Osaka, Japan; and Shanghai, China.